FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
FIELD OF THE INVENTION
This invention relates to the use of Lactobacillus reuteri for the inhibition of disease states associated with Cryptosporidium parvum.
BACKGROUND OF INVENTION
Cryptosporidiosis is caused by the protozoan parasite Cryptosporidium parvum (C. parvum). Historically, C. parvum had
FIELD OF THE INVENTION
This invention relates to the use of Lactobacillus acidophilus for the inhibition of disease states associated with Cryptosporidium parvum.
BACKGROUND OF INVENTION
Cryptosporidiosis is caused by the protozoan parasite Cryptosporidium parvum (C. parvum). Historically, C. parvum
This application is a U.S. National Stage of International Patent Application No. PCT/AU2014/050009, filed Apr. 2, 2014, which in turn claims priority to Australian Patent Application No. 2013901171, filed Apr. 5, 2013, priority of which is also claimed herein. The entire content of the foregoing
Den mest komplette databasen med medisinske urter støttet av vitenskap
Fungerer på 55 språk
Urtekurer støttet av vitenskap
Urtegjenkjenning etter bilde
Interaktivt GPS-kart - merk urter på stedet (kommer snart)
Les vitenskapelige publikasjoner relatert til søket ditt
Søk medisinske urter etter deres effekter
Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot. * All informasjon er basert på publisert vitenskapelig forskning